ROIS, the CDMO arm of ROVI has announced closing the acquisition of an injectable drug product manufacturing and packaging site in Phoenix, Arizona (USA) from Bristol Myers Squibb.
Lupin has announced the completion of its acquisition of VISUfarma, a European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO).
Adragos Pharma, a global contract development and manufacturing organisation (CDMO), has announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi.
Samsung Biologics has announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States.
Bracco Imaging announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced Investments in the site since 2019.
Ampacet has introduced ProVital+ Gamma-Protect, a medical-grade additive designed to preserve mechanical and optical properties of polypropylene-based medical and pharmaceutical articles during gamma and e-beam sterilisation processes.
Critical Manufacturing, the Industrial Operations Platform company that unites execution, connectivity, analytics and trusted AI, will exhibit at Hannover Messe, demonstrating how manufacturers can transform production complexity into operations.
